Quick Answer
Ensysce Biosciences, Inc. reported Shares Outstanding of 4.57 million shares for fiscal year 2025.
Ensysce Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 4.57M | +237.4% |
| 2024 | 1.36M | +546.4% |
| 2023 | 209,739 | -60.8% |
| 2022 | 534,490 | -56.6% |
| 2021 | 1.23M | +296.2% |
| 2021 | 310,963 | -98.0% |
| 2020 | 15.77M | +147.3% |
| 2019 | 6.38M | +5.6% |
| 2018 | 6.04M | -10.3% |
| 2017 | 6.73M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 3.18M | -77.1% | +32.9% |
| June 30, 2025 | 2.39M | -70.6% | +45.5% |
| March 31, 2025 | 1.64M | -77.6% | +21.3% |
| December 31, 2024 | 1.36M | -56.9% | -90.2% |
| September 30, 2024 | 13.87M | +384.3% | +70.2% |
| June 30, 2024 | 8.15M | +205.3% | +11.2% |
| March 31, 2024 | 7.33M | +470.5% | +133.0% |
| December 31, 2023 | 3.15M | +488.6% | +9.8% |
- Ensysce Biosciences, Inc. showed an increase of +237.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, Ensysce Biosciences, Inc.’s shares outstanding has declined by 32.1% (from 6.73 million shares to 4.57 million shares).
- The most recent figure is from Ensysce Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: